R&D & INNOVATION / SECONDARY RESEARCH / PHASE 2 / BIOTECH + PHARMA
RNA delivery systems for extrahepatic therapies
A detailed hypothetical trend-analysis engagement.
INDUSTRY
Biotech + Pharma
SIGNALS
12+ indicators
OUTPUT
Decision lanes
TIMELINE
Illustrative 5-7 weeks
The challenge
A platform team needs to decide which lipid, polymer, conjugate and targeting approaches are moving beyond broad scientific interest toward application-specific evidence for extrahepatic delivery. The work must distinguish elegant preclinical claims from signals that could influence manufacturability, repeat dosing, biodistribution, safety and development strategy.
WHY THE QUESTION IS TIMELY
The external environment is changing quickly. The study would treat regulatory, market, customer and technology developments as dated signals, then test whether they converge around the client’s specific application and decision boundary.
How the research would be executed
Define the technical system, use case, geography, time horizon and technical exclusions.
Search and code events across science, IP, products, partnerships, regulations, capital and ecosystem activity.
Check source independence, technical relevance, date, application context and evidence quality.
Identify acceleration, weak signals, contradictions, decision implications and reassessment triggers.
Observable signals reviewed
Scientific output, patent-family expansion, conference activity, partnerships, financing, platform launches, manufacturing investment, analytical developments and regulatory-science signals are time-coded by payload, target tissue, delivery mechanism and model relevance.
Science + IP
Technical evidence and patent trajectory.
Translation
Pilots, products, validation and scale-up.
Ecosystem
Partners, funding, M&A and portfolio movement.
Regulation + standards
Requirements, guidance, test methods and policy.
Demand + adoption
Procurement, workflow, customer and replacement signals.
Evidence quality
Rate of change, persistence and corroboration.
Illustrative visual output
This example uses a distinct visual form so the engagement can be understood at a glance without repeating the Phase 1 service-page horizon.
What the decision output might say
A portfolio-level trend view may show a small number of delivery routes with cross-source momentum but unresolved repeat-dose or scale-up questions, alongside routes that remain promising science rather than near-term platform choices.
WEBSITE PRESENTATION SUGGESTION
A momentum curve by technical layer, with signal cards that reveal the supporting evidence and the assumptions behind each interpretation.
Illustrative delivery package
- A dated, coded evidence database with source links, technical tags, organisation fields and confidence labels.
- A trend workbook showing rate of change, convergence, gaps and event-level signals across the selected evidence families.
- A decision presentation translating each technical route into act, build evidence, monitor or watchlist lanes.
- A focused shortlist of developers, partners, suppliers or research organisations for follow-on scouting or primary research.
Let's discuss your project
August Research can tailor this trend-analysis structure to the application, technical evidence and roadmap decision in front of your team.
Note: This is a hypothetical website example, not a client engagement or a finding about a technology, organisation or regulatory outcome. All values, record counts and timings are illustrative.
